This inventor holds 1 USPTO granted patent. Top assignee: Diacrin, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovations of Albert S B Edge: Pioneering Porcine MHC Class I Genes
Introduction: Albert S B Edge is a notable inventor based in Cambridge, MA, recognized for his contributions to the field of biotechnology. With a focus on porcine MHC class I genes, Edge's work has significant implications for enhancing immunological tolerance in transplant recipients.
Latest Patents: Edge holds a patent for "Porcine MHC Class I Genes and Uses Thereof." This innovation centers around the utilization of porcine MHC class I genes and the polypeptides they encode, aimed at inducing graft-specific immunological tolerance. This groundbreaking application is vital for individuals receiving porcine cell or organ transplants and facilitates the generation of beneficial antibodies.
Career Highlights: Albert S B Edge's career is marked by his role at Diacrin, Inc., a company dedicated to pioneering research in biotechnology. His expertise and innovative mindset play a crucial role in the development of technologies that improve medical treatments and transplant methodologies.
Collaborations: Throughout his career, Edge has collaborated with prominent figures in the field, including Henry F Oettinger. Together, their combined knowledge and research have contributed to advancing the understanding and application of porcine genetics in medicine.
Conclusion: Albert S B Edge stands out as an influential inventor who has significantly impacted biotechnology through his patent on porcine MHC class I genes. His work not only enhances the potential for successful organ transplants but also establishes a foundation for future innovations in immunological research.